MPS Pharmaa Ltd | 7.63 Cr. | 3.99 | 4.33/3.05 | | 0.80 | 0.00 % | 9.15 % | 34.9 % | 10.0 |
Gujarat Themis Biosyn Ltd | 2,312 Cr. | 212 | 390/192 | 43.9 | 20.5 | 0.31 % | 45.0 % | 33.8 % | 1.00 |
Gujarat Terce Laboratories Ltd | 49.4 Cr. | 66.6 | 94.9/30.8 | 16.8 | 11.9 | 0.00 % | 9.72 % | 3.44 % | 10.0 |
Gujarat Inject (Kerala) Ltd | 38.6 Cr. | 26.3 | 28.6/8.74 | 39.4 | 6.64 | 0.00 % | 2.65 % | 2.08 % | 10.0 |
Godavari Drugs Ltd | 63.3 Cr. | 84.0 | 155/82.2 | 10.2 | 55.4 | 0.00 % | 14.4 % | 15.5 % | 10.0 |
Glenmark Life Sciences Ltd | 13,316 Cr. | 1,084 | 1,335/666 | 31.4 | 207 | 2.07 % | 28.1 % | 21.1 % | 2.00 |
Gennex Laboratories Ltd | 287 Cr. | 12.6 | 29.0/11.5 | 15.4 | 7.93 | 0.00 % | 14.1 % | 10.2 % | 1.00 |
Ganga Pharmaceuticals Ltd | 8.22 Cr. | 17.0 | 27.1/13.3 | 164 | 14.6 | 0.00 % | 3.06 % | 0.80 % | 10.0 |
Fredun Pharmaceuticals Ltd | 308 Cr. | 655 | 1,024/635 | 16.4 | 278 | 0.11 % | 17.1 % | 14.3 % | 10.0 |
Fervent Synergies Ltd | 101 Cr. | 23.2 | 32.0/14.6 | | 8.11 | 0.00 % | 34.8 % | 34.9 % | 10.0 |
Fermenta Biotech Ltd | 821 Cr. | 279 | 449/145 | 23.3 | 98.6 | 0.45 % | 3.20 % | 5.59 % | 5.00 |
Fabino Enterprises Ltd | 5.75 Cr. | 27.4 | 39.6/23.6 | 115 | 20.0 | 0.00 % | 1.68 % | 1.21 % | 10.0 |
Evoq Remedies Ltd | 14.7 Cr. | 5.90 | 14.0/5.55 | 32.6 | 18.6 | 0.00 % | 1.91 % | 1.80 % | 10.0 |
Everest Organics Ltd | 249 Cr. | 256 | 307/110 | | 50.6 | 0.00 % | 6.05 % | 0.30 % | 10.0 |
Entero Healthcare Solutions Ltd | 5,461 Cr. | 1,255 | 1,584/970 | 60.6 | 387 | 0.00 % | 6.71 % | 4.98 % | 10.0 |
Murae Organisor Ltd | 164 Cr. | 1.76 | 2.72/1.03 | 34.7 | 2.85 | 0.00 % | 0.79 % | 0.13 % | 2.00 |
Dipna Pharmachem Ltd | 29.5 Cr. | 12.3 | 16.6/6.40 | 35.6 | 15.8 | 0.00 % | 7.05 % | 3.52 % | 10.0 |
Decipher Labs Ltd | 12.1 Cr. | 12.0 | 24.6/11.0 | 52.7 | 21.3 | 0.00 % | 3.09 % | 6.75 % | 10.0 |
Coral Laboratories Ltd | 282 Cr. | 790 | 999/345 | 10.4 | 570 | 0.25 % | 12.6 % | 9.58 % | 10.0 |
Concord Drugs Ltd | 32.0 Cr. | 32.0 | 45.0/28.5 | | 33.9 | 0.00 % | 4.48 % | 1.28 % | 10.0 |
Colinz Laboratories Ltd | 20.0 Cr. | 43.7 | 84.4/36.0 | 40.8 | 20.5 | 0.00 % | 7.70 % | 5.73 % | 10.0 |
Cian Healthcare Ltd | 9.32 Cr. | 3.73 | 26.5/2.97 | 37.3 | 23.1 | 0.00 % | 5.22 % | 0.43 % | 10.0 |
Chemo Pharma Laboratories Ltd | 10.6 Cr. | 70.7 | 154/52.2 | 26.5 | 91.1 | 0.00 % | 13.3 % | 9.67 % | 10.0 |
Checkpoint Trends Ltd | 8.59 Cr. | 15.7 | 17.4/6.08 | | 0.93 | 0.00 % | 3.36 % | 5.77 % | 10.0 |
Chandra Bhagat Pharma Ltd | 47.5 Cr. | 63.0 | 145/58.0 | 30.1 | 39.4 | 0.00 % | 7.95 % | 5.42 % | 10.0 |
Brawn Biotech Ltd | 6.61 Cr. | 22.0 | 27.8/15.5 | | 14.1 | 0.00 % | 25.9 % | 21.8 % | 10.0 |
Blue Jet Healthcare Ltd | 13,041 Cr. | 752 | 845/329 | 55.6 | 53.3 | 0.13 % | 30.0 % | 22.4 % | 2.00 |
Bharat Immunological & Biological Corporation Ltd | 90.1 Cr. | 20.9 | 35.9/19.0 | | 18.2 | 0.00 % | 9.27 % | 17.7 % | 10.0 |
Beryl Drugs Ltd | 13.3 Cr. | 26.3 | 46.0/24.2 | 166 | 18.3 | 0.00 % | 11.6 % | 8.95 % | 10.0 |
BDH Industries Ltd | 163 Cr. | 284 | 418/279 | 16.8 | 110 | 1.59 % | 20.6 % | 16.9 % | 10.0 |
Bacil Pharma Ltd | 25.7 Cr. | 43.6 | 62.6/8.33 | 73.4 | 2.87 | 0.00 % | 13.1 % | 13.8 % | 10.0 |
Aurobindo Pharma Ltd | 68,139 Cr. | 1,163 | 1,593/984 | 19.2 | 527 | 0.39 % | 14.1 % | 11.5 % | 1.00 |
Auro Laboratories Ltd | 124 Cr. | 200 | 307/137 | 35.7 | 69.6 | 0.00 % | 20.4 % | 20.5 % | 10.0 |
Anuh Pharma Ltd | 814 Cr. | 163 | 265/160 | 16.2 | 60.5 | 1.54 % | 25.6 % | 19.5 % | 5.00 |
ANG Lifesciences India Ltd | 44.6 Cr. | 34.2 | 68.7/32.5 | | 56.2 | 0.00 % | 1.78 % | 8.72 % | 10.0 |
Ami Organics Ltd | 8,977 Cr. | 2,193 | 2,644/1,004 | 73.8 | 294 | 0.14 % | 16.0 % | 9.37 % | 10.0 |
Amerise Biosciences Ltd | 5.74 Cr. | 0.87 | 1.45/0.55 | | 0.80 | 0.00 % | 2.73 % | 2.75 % | 1.00 |
Ambalal Sarabhai Enterprises Ltd | 331 Cr. | 43.2 | 77.7/39.2 | 23.3 | 18.3 | 0.00 % | 7.08 % | 4.22 % | 10.0 |
Adline Chem Lab Ltd | 9.51 Cr. | 16.2 | 27.3/11.9 | | 2.70 | 0.00 % | % | % | 10.0 |
Achyut Healthcare Ltd | 94.5 Cr. | 4.01 | 6.25/2.87 | 143 | 1.32 | 0.00 % | 3.27 % | 2.52 % | 1.00 |
Abbott India Ltd | 62,288 Cr. | 29,326 | 30,683/25,200 | 46.7 | 1,657 | 1.40 % | 46.0 % | 34.9 % | 10.0 |
Aarti Pharmalabs Ltd | 7,344 Cr. | 809 | 825/381 | 29.5 | 205 | 0.37 % | 16.6 % | 13.1 % | 5.00 |
Aarey Drugs & Pharmaceuticals Ltd | 115 Cr. | 40.4 | 75.8/37.0 | 20.1 | 48.5 | 0.00 % | 6.09 % | 3.74 % | 10.0 |
Zota Health Care Ltd | 2,331 Cr. | 850 | 1,078/440 | | 58.0 | 0.12 % | 7.32 % | 16.8 % | 10.0 |
Wockhardt Ltd | 22,035 Cr. | 1,357 | 1,680/489 | | 209 | 0.00 % | 0.83 % | 12.1 % | 5.00 |
Wanbury Ltd | 638 Cr. | 196 | 325/122 | 34.4 | 11.8 | 0.00 % | 60.6 % | % | 10.0 |
Vivimed Labs Ltd | 41.0 Cr. | 4.95 | / | | 3.12 | 0.00 % | 9.38 % | 233 % | 2.00 |
Venus Remedies Ltd | 409 Cr. | 303 | 428/270 | 14.7 | 370 | 0.00 % | 8.57 % | 5.94 % | 10.0 |
Unichem Laboratories Ltd | 4,628 Cr. | 656 | 950/433 | 54.7 | 341 | 0.00 % | 0.39 % | 1.17 % | 2.00 |
TTK Healthcare Ltd | 1,706 Cr. | 1,190 | 1,923/1,190 | 24.9 | 735 | 0.84 % | 8.67 % | 6.43 % | 10.0 |
Torrent Pharmaceuticals Ltd | 1,03,278 Cr. | 3,051 | 3,591/2,488 | 55.5 | 222 | 0.92 % | 23.2 % | 24.2 % | 5.00 |
Themis Medicare Ltd | 1,496 Cr. | 162 | 317/159 | 32.4 | 44.8 | 0.31 % | 13.5 % | 11.8 % | 1.00 |
Syncom Formulations (India) Ltd | 1,567 Cr. | 16.7 | 27.9/11.0 | 41.1 | 3.32 | 0.00 % | 10.2 % | 8.51 % | 1.00 |
Suven Pharmaceuticals Ltd | 27,895 Cr. | 1,095 | 1,360/597 | 100.0 | 77.7 | 0.00 % | 18.8 % | 14.1 % | 1.00 |
Suven Life Sciences Ltd | 2,434 Cr. | 112 | 169/83.0 | | 8.84 | 0.00 % | 36.4 % | 36.3 % | 1.00 |
Sun Pharmaceuticals Industries Ltd | 4,08,461 Cr. | 1,702 | 1,960/1,377 | 34.6 | 288 | 0.79 % | 17.3 % | 16.7 % | 1.00 |
Solara Active Pharma Sciences Ltd | 2,028 Cr. | 482 | 886/327 | | 301 | 0.00 % | 8.67 % | 33.5 % | 10.0 |
SMS Pharmaceuticals Ltd | 1,579 Cr. | 186 | 398/140 | 24.8 | 70.6 | 0.22 % | 11.2 % | 9.27 % | 1.00 |
SMS Lifesciences India Ltd | 374 Cr. | 1,172 | 1,750/551 | 17.8 | 621 | 0.13 % | 6.89 % | 3.66 % | 10.0 |
Shilpa Medicare Ltd | 6,275 Cr. | 642 | 960/384 | 74.1 | 238 | 0.00 % | 5.25 % | 1.71 % | 1.00 |
Sequent Scientific Ltd | 3,705 Cr. | 148 | 241/91.8 | 246 | 27.2 | 0.00 % | 0.44 % | 3.09 % | 2.00 |
Sanofi India Ltd | 11,984 Cr. | 5,188 | 7,600/4,146 | 28.4 | 298 | 3.22 % | 71.1 % | 51.5 % | 10.0 |
RPG Life Sciences Ltd | 3,604 Cr. | 2,180 | 2,977/1,360 | 37.7 | 229 | 0.73 % | 34.6 % | 25.5 % | 8.00 |
Procter & Gamble Health Ltd | 8,778 Cr. | 5,286 | 5,850/4,637 | 35.8 | 368 | 1.52 % | 45.0 % | 33.5 % | 10.0 |
Pharmaids Pharmaceuticals Ltd | 218 Cr. | 62.0 | 87.5/31.9 | | 19.0 | 0.00 % | 27.6 % | 16.8 % | 10.0 |
Pfizer Ltd | 18,849 Cr. | 4,130 | 6,453/3,950 | 30.6 | 820 | 0.85 % | 22.0 % | 16.1 % | 10.0 |
Par Drugs & Chemicals Ltd | 175 Cr. | 142 | 348/142 | 11.3 | 78.6 | 0.00 % | 25.0 % | 18.5 % | 10.0 |
Panacea Biotec Ltd | 1,956 Cr. | 322 | 491/112 | | 136 | 0.00 % | 3.57 % | 3.17 % | 1.00 |
Ortin Laboratories Ltd | 16.4 Cr. | 20.1 | 26.4/16.2 | | 3.47 | 0.00 % | 60.2 % | 118 % | 10.0 |
Orchid Pharma Ltd | 4,142 Cr. | 818 | 1,998/800 | 37.5 | 241 | 0.00 % | 9.37 % | 9.94 % | 10.0 |
Neuland Laboratories Ltd | 14,129 Cr. | 11,032 | 18,100/5,532 | 58.9 | 1,087 | 0.13 % | 33.3 % | 26.4 % | 10.0 |
Nectar Lifescience Ltd | 610 Cr. | 27.2 | 56.5/26.2 | 35.9 | 48.1 | 0.00 % | 5.97 % | 0.46 % | 1.00 |
Natco Pharma Ltd | 14,953 Cr. | 835 | 1,639/822 | 8.02 | 399 | 1.14 % | 30.1 % | 25.9 % | 2.00 |
Morepen Laboratories Ltd | 2,733 Cr. | 49.9 | 101/38.6 | 21.7 | 20.3 | 0.00 % | 16.8 % | 12.0 % | 2.00 |
Marksans Pharma Ltd | 10,891 Cr. | 239 | 359/126 | 29.6 | 50.3 | 0.25 % | 20.6 % | 16.5 % | 1.00 |
Mangalam Drugs and Organics Ltd | 168 Cr. | 107 | 145/85.2 | 16.3 | 93.2 | 0.00 % | 1.19 % | 6.12 % | 10.0 |
Lyka Labs Ltd | 408 Cr. | 114 | 177/97.9 | 99.5 | 27.7 | 0.00 % | 3.53 % | 5.07 % | 10.0 |
Lupin Ltd | 91,777 Cr. | 2,009 | 2,403/1,493 | 32.0 | 343 | 0.40 % | 15.7 % | 14.1 % | 2.00 |
Lincoln Pharmaceuticals Ltd | 1,142 Cr. | 568 | 980/498 | 12.8 | 319 | 0.32 % | 22.3 % | 16.8 % | 10.0 |
Laurus Labs Ltd | 29,446 Cr. | 546 | 646/372 | 118 | 79.2 | 0.15 % | 7.50 % | 5.43 % | 2.00 |
Kwality Pharmaceuticals Ltd | 727 Cr. | 701 | 1,070/405 | 20.6 | 234 | 0.00 % | 15.9 % | 13.7 % | 10.0 |
Krebs Biochemicals & Industries Ltd | 181 Cr. | 82.0 | 129/60.0 | | 60.4 | 0.00 % | 19.0 % | % | 10.0 |
Kopran Ltd | 848 Cr. | 175 | 370/158 | 17.9 | 103 | 1.72 % | 13.8 % | 11.0 % | 10.0 |
Kilitch Drugs (India) Ltd | 490 Cr. | 306 | 435/294 | 27.4 | 118 | 0.00 % | 12.6 % | 7.71 % | 10.0 |
Jubilant Pharmova Ltd | 15,954 Cr. | 1,003 | 1,310/538 | 47.9 | 373 | 0.50 % | 6.74 % | 0.76 % | 1.00 |
J B Chemicals & Pharmaceuticals Ltd | 25,053 Cr. | 1,614 | 2,030/1,474 | 39.1 | 207 | 0.76 % | 24.6 % | 20.0 % | 1.00 |
Jagsonpal Pharmaceuticals Ltd | 1,427 Cr. | 215 | 328/108 | 39.2 | 29.7 | 0.93 % | 17.0 % | 13.0 % | 2.00 |
Ipca Laboratories Ltd | 37,405 Cr. | 1,473 | 1,758/1,052 | 50.9 | 264 | 0.27 % | 12.8 % | 9.35 % | 1.00 |
IOL Chemicals & Pharmaceuticals Ltd | 1,952 Cr. | 332 | 538/330 | 20.0 | 283 | 1.51 % | 12.3 % | 8.68 % | 10.0 |
Ind-Swift Ltd | 74.4 Cr. | 13.8 | 34.7/13.2 | 1.16 | 122 | 0.00 % | 13.4 % | % | 2.00 |
Ind-Swift Laboratories Ltd | 538 Cr. | 90.8 | 186/85.1 | 6.51 | 171 | 0.00 % | 19.6 % | 17.4 % | 10.0 |
Indoco Remedies Ltd | 2,262 Cr. | 247 | 388/241 | | 118 | 0.60 % | 10.4 % | 8.33 % | 2.00 |
Hikal Ltd | 4,254 Cr. | 345 | 465/260 | 57.1 | 97.6 | 0.35 % | 7.79 % | 5.97 % | 2.00 |
Hester Biosciences Ltd | 1,354 Cr. | 1,593 | 3,379/1,293 | 43.8 | 355 | 0.38 % | 9.32 % | 6.60 % | 10.0 |
Gufic BioSciences Ltd | 4,045 Cr. | 403 | 504/278 | 49.3 | 57.3 | 0.02 % | 17.2 % | 20.0 % | 1.00 |
Granules India Ltd | 12,582 Cr. | 519 | 725/382 | 26.3 | 141 | 0.29 % | 15.4 % | 13.4 % | 1.00 |
Glenmark Pharmaceuticals Ltd | 38,898 Cr. | 1,379 | 1,831/867 | | 299 | 0.18 % | 12.3 % | 50.9 % | 1.00 |
Glaxosmithkline Pharmaceuticals Ltd | 43,123 Cr. | 2,537 | 3,088/1,825 | 50.5 | 98.7 | 1.26 % | 51.3 % | 37.3 % | 10.0 |
Gland Pharma Ltd | 24,208 Cr. | 1,471 | 2,221/1,411 | 21.6 | 557 | 1.36 % | 16.7 % | 12.3 % | 1.00 |
FDC Ltd | 6,617 Cr. | 406 | 659/391 | 24.1 | 141 | 1.23 % | 18.4 % | 14.2 % | 1.00 |
ERIS Lifesciences Ltd | 17,007 Cr. | 1,249 | 1,594/809 | 51.6 | 204 | 0.59 % | 11.3 % | 16.3 % | 1.00 |
Dr Reddys Laboratories Ltd | 99,847 Cr. | 1,197 | 1,421/1,120 | 18.6 | 369 | 0.67 % | 26.5 % | 21.4 % | 1.00 |
Dishman Carbogen Amcis Ltd | 3,314 Cr. | 211 | 308/133 | | 366 | 0.00 % | 0.02 % | 2.64 % | 2.00 |
Cipla Ltd | 1,19,818 Cr. | 1,482 | 1,702/1,317 | 24.1 | 351 | 0.88 % | 22.8 % | 16.8 % | 2.00 |
Caplin Point Laboratories Ltd | 14,720 Cr. | 1,933 | 2,641/1,221 | 28.6 | 334 | 0.26 % | 26.5 % | 24.2 % | 2.00 |
Brooks Laboratories Ltd | 311 Cr. | 119 | 203/72.5 | | 22.6 | 0.00 % | 24.7 % | 28.1 % | 10.0 |
Bliss GVS Pharma Ltd | 1,377 Cr. | 131 | 186/92.2 | 16.3 | 95.8 | 0.38 % | 14.4 % | 10.2 % | 1.00 |
Biofil Chemicals & Pharmaceuticals Ltd | 78.0 Cr. | 47.8 | 92.0/46.5 | 130 | 11.3 | 0.00 % | 4.94 % | 4.00 % | 10.0 |
Biocon Ltd | 40,575 Cr. | 338 | 405/244 | 49.3 | 175 | 0.15 % | 5.96 % | 5.25 % | 5.00 |
Beta Drugs Ltd | 1,620 Cr. | 1,685 | 2,326/1,060 | 39.5 | 188 | 0.00 % | 32.8 % | 26.0 % | 10.0 |
Bal Pharma Ltd | 148 Cr. | 93.3 | 158/88.5 | 20.4 | 43.2 | 1.29 % | 12.1 % | 11.0 % | 10.0 |
Bafna Pharmaceuticals Ltd | 171 Cr. | 72.5 | 113/67.8 | 36.5 | 35.0 | 0.00 % | 9.48 % | 9.44 % | 10.0 |
Astrazeneca Pharma India Ltd | 17,388 Cr. | 6,977 | 8,140/4,050 | 104 | 272 | 0.34 % | 31.1 % | 22.9 % | 2.00 |
Amrutanjan Health Care Ltd | 1,727 Cr. | 598 | 863/585 | 35.0 | 103 | 0.77 % | 21.3 % | 15.5 % | 1.00 |
Alpa Laboratories Ltd | 224 Cr. | 107 | 145/69.9 | 8.91 | 83.0 | 0.00 % | 13.7 % | 11.2 % | 10.0 |
Alkem Laboratories Ltd | 56,568 Cr. | 4,722 | 6,440/4,407 | 26.2 | 961 | 0.85 % | 19.7 % | 19.6 % | 2.00 |
Alembic Pharmaceuticals Ltd | 15,932 Cr. | 809 | 1,304/788 | 26.8 | 249 | 1.36 % | 13.1 % | 13.3 % | 2.00 |
Albert David Ltd | 507 Cr. | 889 | 1,754/812 | 12.5 | 724 | 1.29 % | 27.8 % | 21.7 % | 10.0 |
Ajanta Pharma Ltd | 34,483 Cr. | 2,756 | 3,486/1,998 | 38.4 | 294 | 1.31 % | 31.6 % | 23.2 % | 2.00 |
Advanced Enzyme Technologies Ltd | 3,288 Cr. | 294 | 571/292 | 23.1 | 120 | 1.73 % | 15.2 % | 11.2 % | 2.00 |
Aarti Drugs Limited | 3,493 Cr. | 381 | 635/370 | 26.5 | 126 | 0.26 % | 13.7 % | 12.4 % | 10.0 |
Industry Average | 17,509.31 Cr | 1,059.44 | | 42.71 | 185.20 | 0.37% | 16.18% | 16.43% | 6.27 |